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A “U” curve phenomenon can be described for serum
cholesterol, BMI (and many other measurements). Is it
a reason to neglect hypercholesterolemia or obesity?
Emphasizing the “U” curve artificial phenomenon must
not conceal the real drama of dialysis today, i.e., the
poor control of BP which continues to lead patients to
cardiovascular complications and premature death.
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Fig. 1. Systolic post-dialysis hypertension and cardiac-related mortality
(time-varying), 1992–1994/97, adjusted for age, ethnicity, gender, pri-
 1999 by the International Society of Nephrology mary diagnosis, serum albumin and Kt/V. **P , 0.01 vs. 140–149.
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and rat kidney [2, 3]. In situ hybridization analysis dem-Immunohistochemical
onstrated long isoform receptor expression in the inner
medulla and pyramids of mouse kidney, possibly associ-localization of leptin in
ated with collecting tubules and ducts [3]. Furthermore,
in rat kidney, autoradiographic studies have shown leptinrat kidney
binding to areas of the internal medulla [4]. To localize
the specific cells where leptin binds, we have produced
a monoclonal antibody (3H10, IgG2b) against a rat leptin
synthetic peptide, AFSKSCSLPQTRGLQKPESL, andTo the Editor: In a recent issue of Kidney International
used it in immunohistochemical studies [5].[1] the relationship of leptin and its receptors in the
The results show intense leptin labelling at the apicalkidney is discussed, but as the authors point out, more
membrane and cytoplasm of inner medullary collectingstudies are necessary to understand the role of leptin in
duct cells, whereas in the rest of the collecting ducts andthe kidney. Here, we report novel data that may help to
tubules a weak staining was found. These results arebetter understand this open field.
consistent with localization studies showing an occur-Using RT-PCR and Northern blot methods, high ex-
pression of leptin receptors has been found in mouse rence of the long isoform of the leptin receptor (ob-Rb) in
Fig. 1. Immunoperoxidase localization of
leptin in rat kidney. (A) Section was incubated
for 2 hours with 3H10 antibody. Arrowhead
shows immunoreactivity at the luminal mem-
brane of inner medullary collecting duct cells.
Arrow points to intracellular staining. (B)
Negative control; section was incubated for 2
hours with 3H10 antibody previously ab-
sorbed with its immunogen.
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